Eligibility
Applicants:
If the proposed project falls within Cure Parkinson’s scope for funding, it will be considered by our independent research committee, which meets on a quarterly basis.
At each meeting, the committee discuss new applications and decide whether they should be evaluated further. If they decide that an application should be considered for funding, the application will be sent for external peer review. The feedback from these expert reviews will be discussed at the next research committee meeting, and a recommendation on whether to fund the project will be made for the Cure Parkinson’s trustees to consider. For successful applicants, the process takes approximately three months but can take longer, particularly for clinical trials where an iterative approach may apply.
All successful and unsuccessful applicants will be notified by the chair of the research committee and/or suitable senior Cure Parkinson’s representative.
To submit your application, please download and complete the relevant forms below then email these as attachments to Research Manager, Rosie Fuest.
Summary
Cure Parkinson´s seeks to fund preclinical and clinical research that have the potential to cure Parkinson´s disease. “Cure” relates to therapies that can slow, stop or reverse Parkinson´s disease. Researchers worldwide are encouraged to submit proposals for pre-clinical studies and clinical trials and research projects that have the potential to be translated into the clinic in the coming five years. Key areas include stopping disease progression, restorative therapy – cell replacement, and protecting nerve cells in the brain.
Cure Parkinson’s is not restricted to clinical trial-related work and will consider funding other important promising (laboratory and non-clinical) research which has potential to lead to a cure for Parkinson’s. This can also include funding any other research supporting or accelerating clinical trials and their outcomes, including clinical trial design, research into exploratory outcome measures, cohort definition, patient stratification, genetic data collection (e.g. bio-banking of samples), flexible bridging support (extension funding) for trials running into difficulties, screening libraries with appropriate assays, carrying out epidemiological studies, novel approaches to treatment or new methods of treatment delivery. Review the full Research Strategy (Link: https://cureparkinsons.org.uk/our-research-strategy/) for more information on the types of research Cure Parkinson's funds and the organization's funding priorities.